Literature DB >> 15246872

Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.

Filip Golebiowski1, Aneta Szulc, Andrzej Szutowicz, Tadeusz Pawelczyk.   

Abstract

Fhit protein is the product of the putative tumor suppressor fragile histidine triad (FHIT) gene. The way by which Fhit exerts its antitumor activity remains largely unknown, although the Fhit-Ap3A complex is believed to be the native signaling form of Fhit. Here, we have shown that Fhit protein interacts with hUbc9, a recombinant human SUMO-1 conjugating enzyme, in an adenosine(5')triphospho(5')nucleoside (Ap3N)-dependent manner. Our experiments showed that the dinucleoside polyphosphate hydrolase activity of Fhit is suppressed by interacting with hUbc9 protein. In the presence of equimolar hUbc9 the Vmax and Km activity of Fhit was decreased by 35%. Analysis of Fhit kinetics in the presence of different fixed concentrations of Ubc9 showed that Ubc9 is an uncompetitive inhibitor. Including SUMO-1 protein in the assay neither affected the Fhit activity nor modified the effect of Ubc9 on Fhit kinetics. Our data suggest that hUbc9-induced inhibition of Fhit may result in an elongation of the Fhit-Ap3A signaling complex lifetime leading to alteration of its antitumor activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246872     DOI: 10.1016/j.abb.2004.05.020

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation.

Authors:  Andru Tomoiu; Annie Gravel; Robert M Tanguay; Louis Flamand
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 2.  Fragile histidine triad protein: structure, function, and its association with tumorogenesis.

Authors:  Md Imtaiyaz Hassan; Abdullah Naiyer; Faizan Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-24       Impact factor: 4.553

3.  The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions.

Authors:  G Terry; L Ho; P Londesborough; C Duggan; A Hanby; J Cuzick
Journal:  Br J Cancer       Date:  2006-12-12       Impact factor: 7.640

4.  FHIT down-regulation was inversely linked to aggressive behaviors and adverse prognosis of gastric cancer: a meta- and bioinformatics analysis.

Authors:  Hua-Chuan Zheng; Li-Li Liu
Journal:  Oncotarget       Date:  2017-11-03

5.  Chemical Proteomics of the Tumor Suppressor Fhit Covalently Bound to the Cofactor Ap3A Elucidates Its Inhibitory Action on Translation.

Authors:  Doreen Herzog; Jasmin Jansen; Maite Mißun; Kay Diederichs; Florian Stengel; Andreas Marx
Journal:  J Am Chem Soc       Date:  2022-05-06       Impact factor: 16.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.